Last month a “Progress with PREtec field trials in Brazil” announcement from Plant Health Care (PHC) saw the shares soar towards 9p. They had since slid back to 7.5p – and today a “Pilot production of PREtec peptides” announcement…
Plant Health Care (PHC) “is pleased to provide” an update on field trials of its PREtec peptide PHC279 for the control of Asian Soybean Rust in Brazil – and the shares have responded currently more than 50% higher, towards 9p…
Updating last month on Plant Health Care (PHC), I concluded, with the shares at 10.1p,… “much to be achieved from the reported position - and also having noted previously what happened with some previous confidence from the company - I currently continue to avoid”. Now a near last minute before Christmas “Trading Statement”…
Previously writing on Plant Health Care (PHC) it was on a share price slump earlier this year to circa 15p. The latest is a “Positive Developments with Harpin” announcement – though the shares are currently at 10.1p…
A trading statement from Plant Health Care (PHC) firstly emphasises “on track to achieve full year revenue expectations, which would represent 30% growth over 2017”. So why currently a 33% share price slump, to around 15p?...
In theory share options are there to incentivise management. There is of course scant evidence that directors who are often grossly overpaid will actually work even harder/be less lazy because they get to have a one way bet on the share price. It may encourage actions that drive short term share spikes but is there a proven link between options and value creation? Er... no. What we we do know is that options are not cost free.
Search ShareProphets |
Recent Comments |